Fulcrum Therapeutics Inc (NASDAQ:FULC)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - FULC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - FULC

  • Market Cap$290.450m
  • SymbolNASDAQ:FULC
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS3596161097

Company Profile

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability.

Latest FULC news

Currently there for this company. Visit our news hub for other news .